Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics (WINT)
NASDAQ:WINT
RESEARCH TOOLSreports
Holding WINT?
Track your performance easily
WINT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.89 - $30.06
Previous Close$3.82
Volume2.66K
Average Volume (3M)34.67K
Market Cap
$2.26M
Enterprise Value$1.20M
Total Cash (Recent Filing)$2.55M
Total Debt (Recent Filing)$1.48M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Aug 15, 2024EPS Estimate
-$8.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-38.45
Shares Outstanding591,909
10 Day Avg. Volume24,861
30 Day Avg. Volume34,666
Standard Deviation2.42
R-Squared0.01
Alpha0.15
Financial Highlights & Ratios
Price to Book (P/B)0.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda0.06
Forecast
1Y Price Target
$7.00Price Target Upside89.19% Upside
Rating ConsensusHold
Number of Analyst Covering1
Windtree Therapeutics News
PremiumCompany Announcements
Windtree Therapeutics Appoints Jed Latkin as New CEO
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WINT FAQ
What was Windtree Therapeutics’s price range in the past 12 months?
Windtree Therapeutics lowest stock price was $2.89 and its highest was $30.06 in the past 12 months.
What is Windtree Therapeutics’s market cap?
Currently, no data Available
When is Windtree Therapeutics’s upcoming earnings report date?
Windtree Therapeutics’s upcoming earnings report date is Aug 15, 2024 which is 98 days ago.
How were Windtree Therapeutics’s earnings last quarter?
Currently, no data Available
Is Windtree Therapeutics overvalued?
According to Wall Street analysts Windtree Therapeutics’s price is currently Undervalued.
Does Windtree Therapeutics pay dividends?
Windtree Therapeutics does not currently pay dividends.
What is Windtree Therapeutics’s EPS estimate?
Windtree Therapeutics’s EPS estimate is -$8.11.
How many shares outstanding does Windtree Therapeutics have?
Windtree Therapeutics has 591,909 shares outstanding.
What happened to Windtree Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Windtree Therapeutics?
Among the largest hedge funds holding Windtree Therapeutics’s share is Deerfield Management Company, LP. It holds Windtree Therapeutics’s shares valued at 215K.
---
Windtree Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.00 (89.19% Upside)
$7.00 (89.19% Upside)
Blogger Sentiment
Bearish
WINT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 33.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.39%
12-Months-Change
Fundamentals
Return on Equity
-53.10%
Trailing 12-Months
Asset Growth
-14.44%
Trailing 12-Months
Company Description
Windtree Therapeutics
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
---
WINT Stock 12 Month Forecast
Average Price Target
$7.00
▲(89.19% Upside)
Technical Analysis
---